As health officials continue to track reports of multisystem inflammatory syndrome in children (MIS-C), the American Academy of Pediatrics issued new guidance earlier this month on diagnosing and treating the rare but serious condition associated with COVID-19. The recommendations cover common signs and symptoms, testing guidance, and treatment, and encourage a multidisciplinary approach to managing patients.

As of July 15, the Centers for Disease Control and Prevention (CDC) had received reports of 342 cases of MIS-C, including six deaths, from 36 states and the District of Columbia. About 70% of the reported cases so far have occurred in children who are Hispanic/Latino (120 cases) or Black (104 cases), according to CDC’s website. Most of the children who developed the condition did so 2-4 weeks after infection with SARS-CoV-2.

For additional information about MIS-C, a recording of a PIDS Virtual Townhall, held in May, is available to view online. Key takeaways from the session and related resources are also available on the PIDS website.